Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Relmada Therapeutics Inc (RLMD)

  • Business News
  • Aug. 06, 2026, 16:18 UTC
  • 0
  • 1 comments

Relmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Market reaction Comment Full text

SINCLAIR, INC. (SBGI)

  • Business News
  • Aug. 06, 2026, 16:15 UTC
  • 0
  • 1 comments

Sinclair Commends Removal of Artificial Limits on Local Broadcasters

Market reaction Comment Full text

DXC TECHNOLOGY CO (DXC)

  • Business News
  • Aug. 06, 2026, 16:11 UTC
  • 0
  • 1 comments

DXC et Primary lancent une plateforme Zero Trust native pour lIA destinée aux environnements dentreprise

Market reaction Comment Full text

SUPER MICRO COMPUTER, INC. (SMCI)

  • Business News
  • Aug. 06, 2026, 16:10 UTC
  • 0
  • 1 comments

Supermicros zevende jaarlijkse Open Storage Summit brengt 21 ecosysteempartners samen om praktische richtlijnen te delen over schaalbare implementatie van Enterprise AI

Market reaction Comment Full text

FOUNDATION HEALTHCARE HOLDINGS LIMITED (FHH)

  • Business News
  • Aug. 06, 2026, 16:08 UTC
  • 0
  • 1 comments

General Announcement: Stabilisation Announcement

Market reaction Comment Full text

ALIGNMENT HEALTHCARE, INC. (ALHC)

  • Business News
  • Aug. 06, 2026, 16:07 UTC
  • 0
  • 1 comments

ALHC INVESTOR ALERT: Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors Urged to Contact Hagens Berman; Investigation Opened Following Disappointing Second-Quarter Results and Whistleblower Allegations

Market reaction Comment Full text

MARQETA, INC. (MQ)

  • Business News
  • Aug. 06, 2026, 16:05 UTC
  • 0
  • 1 comments

Marqeta Expands Collaboration with Google to Launch New Offering in Wallet for Kids

Market reaction Comment Full text

AVIS BUDGET GROUP, INC. (CAR)

  • Business News
  • Aug. 06, 2026, 16:00 UTC
  • 0
  • 1 comments

Bronstein, Gewirtz & Grossman LLC Urges Avis Budget Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Market reaction Comment Full text

PHILLIP CAPITAL MANAGEMENT (S) LTD (LSS)

  • Business News
  • Aug. 06, 2026, 16:00 UTC
  • 0
  • 1 comments

LECTRA: Monthly declaration of the total number of shares and voting rights composing the companys capital (at July 31st, 2026)

Market reaction Comment Full text

CAPRICOR THERAPEUTICS, INC. (CAPR)

  • Business News
  • Aug. 06, 2026, 16:00 UTC
  • 0
  • 1 comments

Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Market reaction Comment Full text

SOUTHERN CO (SO)

  • Business News
  • Aug. 06, 2026, 16:00 UTC
  • 0
  • 1 comments

Georgia Power Generation employees keep reliable energy flowing throughout the hottest days of summer

Market reaction Comment Full text

SPHERE ENTERTAINMENT CO. (SPHR)

  • Business News
  • Aug. 06, 2026, 16:00 UTC
  • 0
  • 1 comments

The Wizard of Oz at Sphere Celebrates One Year of Redefining Immersive Storytelling

Market reaction Comment Full text

PHILLIP CAPITAL MANAGEMENT (S) LTD (LSS)

  • Business News
  • Aug. 06, 2026, 16:00 UTC
  • 0
  • 1 comments

LECTRA : Déclaration mensuelle du nombre total dactions et de droits de vote composant le capital social (au 31 juillet 2026)

Market reaction Comment Full text

MINK THERAPEUTICS, INC. (INKT)

  • Business News
  • Aug. 06, 2026, 16:00 UTC
  • 0
  • 1 comments

MiNK Therapeutics Presents Early Observations from Ongoing Phase 2 Trial at the 2026 Military Health System Research Symposium

Market reaction Comment Full text

SEI INVESTMENTS CO (SEIC)

  • Business News
  • Aug. 06, 2026, 16:00 UTC
  • 0
  • 1 comments

SEI Launches ANGU ETF, Bringing Factor Research to Traditional Index Exposure

Market reaction Comment Full text
  • Previous
  • 189
  • 190
  • 191
  • 192
  • 193
  • Next

Search

News categories

  • Technical Exchange News(14168)
  • Event(6229)
  • SEC News(361393)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(222213)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin